Non-Hodgkin Lymphoma News

• Improved Cancer Survival in States with ACA Medicaid Expansion An increase in cancer survival rates has been seen in states that implemented Medicaid expansion under the Affordable Care Act (ACA).
  Medscape Medical News, May 18, 2022
• Nearly 234,000 Cancer Cases Predicted in Canada This Year Although overall cancer rates are declining in Canada, the number of cases and deaths continue to climb due to population growth and an aging population.
  Medscape Medical News, May 13, 2022
• Clozapine and Cancer Risk: New Data Long-term treatment with clozapine is associated with a small, but significant, risk of hematological malignancies in individuals with schizophrenia, new research shows.
  Medscape Medical News, May 12, 2022
• What Do Ultrasound Images Find in Superficial Lumps and Bumps? The Society of Radiologists in Ultrasound offers illustrated clinical tips in a recently published paper to help diagnose and manage commonly identified masses.
  Medscape Medical News, May 12, 2022
• 'Agony of Choice' for Clinicians Treating Leukemia With an abundance of targeted therapies transforming the treatment landscape for chronic lymphocytic leukemia, picking the optimal drug or regimen for the right situation can be a challenge.
  Medscape Medical News, May 11, 2022
• ED Visits, Readmissions Common After CAR T Therapy Toxicities associated with CAR T-cell therapy typically emerge in the first month after treatment, a new analysis suggests.
  Medscape Medical News, May 11, 2022
• CAR-T Outcomes Similar Among Black, Hispanic, White, Asian Patients Black and Hispanic cancer patients who underwent CAR-T therapy at a single center had comparable outcomes to their white and Asian counterparts, researchers say.
  Reuters Health Information, May 10, 2022
• Proton-Beam Therapy Increasingly Popular in the US Physicians in the US are increasingly using proton-beam therapy to treat newly diagnosed cancer patients, a new study finds.
  Reuters Health Information, May 05, 2022
• FDA Panel: Concerns Over PI3K Inhibitors in Blood Cancers An FDA advisory panel voted in favor of using randomized trials of PI3K drugs instead of single-arm studies in blood cancer studies, because of concerns about toxicities in this class of drugs.
  Medscape Medical News, April 22, 2022
• Mother and Baby Fine After First Reported Use of Immune-checkpoint Inhibitor During Pregnancy A woman who suffered a relapse of classic Hodgkin lymphoma while pregnant was successfully treated with the immune-checkpoint inhibitor nivolumab, in what is believed to be the first reported case in the literature.
  Reuters Health Information, April 18, 2022
• When ImmunoTx Fails, HL Patients Should Get Timely Allo-HCT Physicians treating Hodgkin lymphoma should not delay allo-HCT over fears of checkpoint inhibitor-related graft-versus-host disease.
  Medscape Medical News, April 18, 2022
• Survivor's Story Foreshadows One of Oncology's Greatest Successes A patient's story illustrates the tremendous improvement in lymphoma treatments over the last three decades.
  Medscape Medical News, April 18, 2022
• Zanubrutinib Shows Worth Against Standard CLL Drugs Patients with chronic lymphocytic leukemia could soon be offered a novel treatment option after trial data showed zanubrutinib improves outcomes against standard therapies.
  Medscape Medical News, April 13, 2022
• AACR 2022 'Truly Impressive' Responses in Lymphoma With Novel Cell Therapy Activated natural killer cells combined with a bispecific antibody showed strong activity in heavily pretreated patients with lymphoma expressing the CD30 antigen.
  Medscape Medical News, April 11, 2022
• Living in Fear of Cancer Recurrence—Some May Need Help Over half of cancer survivors as well as those with active cancer report at least a moderate level of fear, but about 20% report a high level of fear and may need specialized help.
  Medscape Medical News, April 08, 2022
• First-Line Axi-cel Therapy Effective in High-Risk Large-B-Cell Lymphoma New research supports the use of axicabtagene ciloleucel (axi-cel) as first-line treatment for patients with high-risk large-B-cell lymphoma.
  Reuters Health Information, March 24, 2022
• ODAC 2022 Treating a Child With Severe AD: From Topicals to Biologics "Many patients who have failed topical steroids have never had adequate treatment," according to A. Yasmine Kirkorian, MD.
  Medscape Medical News, March 03, 2022
• Handle With Care: Managing IBD in Older Patients Patients aged 60 years and older with chronic or newly diagnosed IBD may have comorbidities or use medications that can interfere with IBD therapies.
  Medscape Medical News, February 15, 2022
• New PET Tracer Detects More Metastases in Cancer Patients A new product that homes in on fibroblast activation protein may be a "paradigm shift" to better identification and targeting of many cancers, say experts.
  Medscape Medical News, February 08, 2022
• Support for Fourth COVID-19 Jab in Blood Cancer Patients For patients with blood cancer, three doses of COVID-19 vaccine may not generate detectable neutralizing antibodies against the Omicron variant of SARS-CoV-2, according to a new study from the UK.
  Reuters Health Information, February 03, 2022